Written by MarketBeatUpdated August 29, 2025 ShareLink copied to clipboard. Key Points Eli Lilly, Allarity Therapeutics, and Novo Nordisk are highlighted as the top pharmaceutical stocks to watch due to their significant recent trading volumes. Allarity Therapeutics focuses on oncology therapeutics and has multiple drug candidates in Phase 2 clinical trials for various types of cancer. Novo Nordisk operates in the Diabetes and Obesity Care market, reflecting its commitment to addressing significant health issues globally. Want stock alerts on Eli Lilly and Company? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts. Like this article? Share it with a colleague. Link copied to clipboard. Featured Articles and OffersNIO Just Got Its Second Upgrade of the Month, and It’s BigBy Sam Quirke | August 28, 2025Elon’s BIGGEST warning yet?From Brownstone Research (Ad)Take Profits Now: 3 Overbought Stocks Primed for a PullbackBy Dan Schmidt | August 25, 2025Buffett’s Wisdom Could Spell Trouble for Palantir ShortsBy Chris Markoch | August 26, 2025Super Micro Computer Stock Hasn't Priced in Growth YetBy Gabriel Osorio-Mazilli | August 25, 2025Small Washington, DC Group Could Crash US StocksFrom Altimetry (Ad)Costco and Ross: 2 Ways to Play the Consumer DivideBy Chris Markoch | August 24, 20253 Cheap Stocks That Shouldn't Be This LowBy Gabriel Osorio-Mazilli | August 25, 2025 Recent Videos Stock ListsAll Stock Lists5G Biotech Blue Chip FAANG Gold Large Cap Marijuana Micro Cap Oil REITs Russell 2000 Small Cap Warren Buffett Investing ToolsCalendars and ToolsAnalyst RatingsCryptocurrency ScreenerCongressional TradingDividend IncreasesDividend CalculatorDividend CalendarEarnings AnnouncementsInsider TradesOptions Profit CalculatorPenny StocksPortfolio MonitoringShort InterestStock ComparisonsStock Market HolidaysStock Screener Search Headlines Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Written by MarketBeatUpdated August 29, 2025 ShareLink copied to clipboard. Key Points Eli Lilly, Allarity Therapeutics, and Novo Nordisk are highlighted as the top pharmaceutical stocks to watch due to their significant recent trading volumes. Allarity Therapeutics focuses on oncology therapeutics and has multiple drug candidates in Phase 2 clinical trials for various types of cancer. Novo Nordisk operates in the Diabetes and Obesity Care market, reflecting its commitment to addressing significant health issues globally. Want stock alerts on Eli Lilly and Company? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts. Like this article? Share it with a colleague. Link copied to clipboard.
